Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Ramosetron is a potent and selective serotonin type 3 receptor antagonist. This meta-analysis aimed to analyze the efficacy and safety of ramosetron for irritable bowel syndrome with diarrhea (IBS-D). METHODS: Pubmed, MEDLINE, EMBASE and the Cochrane Library were searched for randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Qingqing, Zhang, Yan, Chen, Feixue, Zuo, Xiuli, Li, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759234/
https://www.ncbi.nlm.nih.gov/pubmed/29310568
http://dx.doi.org/10.1186/s12876-017-0734-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759234/
https://www.ncbi.nlm.nih.gov/pubmed/29310568
http://dx.doi.org/10.1186/s12876-017-0734-2

Ejemplares similares